{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:50:49Z","timestamp":1790110249547,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,4]]},"DOI":"10.7759\/cureus.49920","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T18:48:26Z","timestamp":1701715706000},"source":"Crossref","is-referenced-by-count":47,"title":["Diagnosis and Treatment of Liver Disease: Current Trends and Future Directions"],"prefix":"10.7759","author":[{"given":"Hina","family":"Wazir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marium","family":"Abid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binish","family":"Essani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ahmad Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FNU","family":"Nasrullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usama","family":"Qadeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ali","family":"Muzammil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areeba","family":"Maryam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Rehman Shah","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Ahad","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Kinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2813.212300","article-title":"Effects of decreased immunization coverage for hepatitis B virus caused by COVID-19 in World Health Organization Western Pacific and African Regions, 2020","volume":"28","author":"Kabore HJ","year":"2022","unstructured":"Kabore HJ, Li X, Allison RD, Avagyan T, Mihigo R, Takashima Y, Tohme RA. Effects of decreased immunization coverage for hepatitis B virus caused by COVID-19 in World Health Organization Western Pacific and African Regions, 2020. Emerg Infect Dis. 2022, 28:S217-24. 10.3201\/eid2813.212300","journal-title":"Emerg Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi ZM","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023, 77:1335-47. 10.1097\/HEP.0000000000000004","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00386-7","article-title":"Global reporting of progress towards elimination of hepatitis B and hepatitis C","volume":"8","author":"Cui F","year":"2023","unstructured":"Cui F, Blach S, Manzengo Mingiedi C, et al.. Global reporting of progress towards elimination of hepatitis B and hepatitis C. Lancet Gastroenterol Hepatol. 2023, 8:332-42. 10.1016\/S2468-1253(22)00386-7","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices","volume":"67","author":"Schillie S","year":"2018","unstructured":"Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, Nelson NP. Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2018, 67:1-31. 10.15585\/mmwr.rr6701a1","journal-title":"MMWR Recomm Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Polaris Observatory HCV Collaborators","year":"2017","unstructured":"Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017, 2:161-76. 10.1016\/S2468-1253(16)30181-9","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28584","article-title":"Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Lonardo A","year":"2016","unstructured":"Lonardo A, Byrne CD, Caldwell SH, Cortez-Pinto H, Targher G. Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016, 64:1388-9. 10.1002\/hep.28584","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2017.08.001","article-title":"Clinical and economic burden of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"22","author":"Younossi ZM","year":"2018","unstructured":"Younossi ZM, Henry L, Bush H, Mishra A. Clinical and economic burden of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis. 2018, 22:1-10. 10.1016\/j.cld.2017.08.001","journal-title":"Clin Liver Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-62619-6.00002-1","article-title":"Perspectives on the neuroscience of alcohol from the National Institute on Alcohol Abuse and Alcoholism","volume":"125","author":"Reilly MT","year":"2014","unstructured":"Reilly MT, Noronha A, Warren K. Perspectives on the neuroscience of alcohol from the National Institute on Alcohol Abuse and Alcoholism. Handb Clin Neurol. 2014, 125:15-29. 10.1016\/B978-0-444-62619-6.00002-1","journal-title":"Handb Clin Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054344","article-title":"Single-cell RNA transcriptome profiling of liver cells of short-term alcoholic liver injury in mice","volume":"24","author":"Cao L","year":"2023","unstructured":"Cao L, Wu D, Qin L, et al.. Single-cell RNA transcriptome profiling of liver cells of short-term alcoholic liver injury in mice. Int J Mol Sci. 2023, 24:4344. 10.3390\/ijms24054344","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.alcohol.2020.04.008","article-title":"Summary of the 2019 alcohol and immunology research interest group (AIRIG) meeting: alcohol-mediated mechanisms of multiple organ injury","volume":"87","author":"McMahan RH","year":"2020","unstructured":"McMahan RH, Afshar M, Amedee AM, et al.. Summary of the 2019 alcohol and immunology research interest group (AIRIG) meeting: alcohol-mediated mechanisms of multiple organ injury. Alcohol. 2020, 87:89-95. 10.1016\/j.alcohol.2020.04.008","journal-title":"Alcohol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao B","year":"2011","unstructured":"Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011, 141:1572-85. 10.1053\/j.gastro.2011.09.002","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1259246","article-title":"Hepatic stellate cell-intrinsic role of SOCS1 in controlling hepatic fibrogenic response and the pro-inflammatory macrophage compartment during liver fibrosis","volume":"14","author":"Kandhi R","year":"2023","unstructured":"Kandhi R, Yeganeh M, Yoshimura A, Menendez A, Ramanathan S, Ilangumaran S. Hepatic stellate cell-intrinsic role of SOCS1 in controlling hepatic fibrogenic response and the pro-inflammatory macrophage compartment during liver fibrosis. Front Immunol. 2023, 14:1259246. 10.3389\/fimmu.2023.1259246","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s P","year":"2021","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG, Sol\u00e0 E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021, 398:1359-76. 10.1016\/S0140-6736(21)01374-X","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz HK","year":"2018","unstructured":"Seitz HK, Bataller R, Cortez-Pinto H, et al.. Alcoholic liver disease. Nat Rev Dis Primers. 2018, 4:16. 10.1038\/s41572-018-0014-7","journal-title":"Nat Rev Dis Primers"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R119000547","article-title":"Alcohol effects on hepatic lipid metabolism","volume":"61","author":"Jeon S","year":"2020","unstructured":"Jeon S, Carr R. Alcohol effects on hepatic lipid metabolism. J Lipid Res. 2020, 61:470-9. 10.1194\/jlr.R119000547","journal-title":"J Lipid Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos A","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: pathophysiological basis for therapy. J Hepatol. 2020, 72:558-77. 10.1016\/j.jhep.2019.10.003","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/add.13757","article-title":"The relationship between different dimensions of alcohol use and the burden of disease-an update","volume":"112","author":"Rehm J","year":"2017","unstructured":"Rehm J, Gmel GE Sr, Gmel G, et al.. The relationship between different dimensions of alcohol use and the burden of disease-an update. Addiction. 2017, 112:968-1001. 10.1111\/add.13757","journal-title":"Addiction"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.469","article-title":"ACG Clinical Guideline: alcoholic liver disease","volume":"113","author":"Singal AK","year":"2018","unstructured":"Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG Clinical Guideline: alcoholic liver disease. Am J Gastroenterol. 2018, 113:175-94. 10.1038\/ajg.2017.469","journal-title":"Am J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004148.pub4","article-title":"Effectiveness of brief alcohol interventions in primary care populations","volume":"2","author":"Kaner EF","year":"2018","unstructured":"Kaner EF, Beyer FR, Muirhead C, et al.. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2018, 2:CD004148. 10.1002\/14651858.CD004148.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.06.012","article-title":"Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits","volume":"77","author":"Peiseler M","year":"2022","unstructured":"Peiseler M, Schwabe R, Hampe J, Kubes P, Heikenw\u00e4lder M, Tacke F. Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits. J Hepatol. 2022, 77:1136-60. 10.1016\/j.jhep.2022.06.012","journal-title":"J Hepatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-023-04883-0","article-title":"Inhibition of integrin binding to ligand arg-gly-asp motif induces AKT-mediated cellular senescence in hepatic stellate cells","volume":"88","author":"Kitsugi K","year":"2023","unstructured":"Kitsugi K, Noritake H, Matsumoto M, et al.. Inhibition of integrin binding to ligand arg-gly-asp motif induces AKT-mediated cellular senescence in hepatic stellate cells. Mol Cell Biochem. 2023, 88:125-72. 10.1007\/s11010-023-04883-0","journal-title":"Mol Cell Biochem"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen N","year":"2020","unstructured":"Roehlen N, Crouchet E, Baumert TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells. 2020, 9:875. 10.3390\/cells9040875","journal-title":"Cells"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2016.12.011","article-title":"The diagnosis and treatment of hepatocellular carcinoma","volume":"34","author":"Hartke J","year":"2017","unstructured":"Hartke J, Johnson M, Ghabril M. The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol. 2017, 34:153-9. 10.1053\/j.semdp.2016.12.011","journal-title":"Semin Diagn Pathol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam M","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020, 158:1999-2014.e1. 10.1053\/j.gastro.2019.11.312","journal-title":"Gastroenterology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.11.010","article-title":"A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes","volume":"78","author":"Ajmera V","year":"2023","unstructured":"Ajmera V, Cepin S, Tesfai K, et al.. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes. J Hepatol. 2023, 78:471-8. 10.1016\/j.jhep.2022.11.010","journal-title":"J Hepatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/life13101987","article-title":"Challenges and solutions in the management of hepatocellular carcinoma associated with non-alcoholic fatty liver disease","volume":"13","author":"Cadar R","year":"2023","unstructured":"Cadar R, Lupascu Ursulescu C, Vasilescu AM, et al.. Challenges and solutions in the management of hepatocellular carcinoma associated with non-alcoholic fatty liver disease. Life (Basel). 2023, 13:1987. 10.3390\/life13101987","journal-title":"Life (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-017-1666-5","article-title":"Comparison between CT and MR images as more favorable reference data sets for fusion imaging-guided radiofrequency ablation or biopsy of hepatic lesions: a prospective study with focus on patient's respiration","volume":"40","author":"Cha DI","year":"2017","unstructured":"Cha DI, Lee MW, Kang TW, et al.. Comparison between CT and MR images as more favorable reference data sets for fusion imaging-guided radiofrequency ablation or biopsy of hepatic lesions: a prospective study with focus on patient's respiration. Cardiovasc Intervent Radiol. 2017, 40:1567-75. 10.1007\/s00270-017-1666-5","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-023-04453-x","article-title":"Smartphone application with 3D-printed needle guide for faster and more accurate CT-guided interventions in a phantom [PREPRINT]","author":"Lui C","year":"2023","unstructured":"Lui C, Polster R, Bullen J, et al.. Smartphone application with 3D-printed needle guide for faster and more accurate CT-guided interventions in a phantom [PREPRINT]. Skeletal Radiol. 2023, 10.1007\/s00256-023-04453-x","journal-title":"Skeletal Radiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32302","article-title":"Influence of liver stiffness heterogeneity on staging fibrosis in patients with nonalcoholic fatty liver disease","volume":"76","author":"Kawamura N","year":"2022","unstructured":"Kawamura N, Imajo K, Kalutkiewicz KJ, et al.. Influence of liver stiffness heterogeneity on staging fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2022, 76:186-95. 10.1002\/hep.32302","journal-title":"Hepatology"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.17235\/reed.2022.8777\/2022","article-title":"Liver stiffness accuracy by magnetic resonance elastography in histologically proven non-alcoholic fatty liver disease patients: a Spanish cohort","volume":"115","author":"Lara Romero C","year":"2023","unstructured":"Lara Romero C, Liang JX, Fern\u00e1ndez Lizaranzazu I, et al.. Liver stiffness accuracy by magnetic resonance elastography in histologically proven non-alcoholic fatty liver disease patients: a Spanish cohort. Rev Esp Enferm Dig. 2023, 115:162-7. 10.17235\/reed.2022.8777\/2022","journal-title":"Rev Esp Enferm Dig"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-015-3949-z","article-title":"Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis","volume":"26","author":"Singh S","year":"2016","unstructured":"Singh S, Venkatesh SK, Loomba R, et al.. Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis. Eur Radiol. 2016, 26:1431-40. 10.1007\/s00330-015-3949-z","journal-title":"Eur Radiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.08.058","article-title":"Application of artificial intelligence to gastroenterology and hepatology","volume":"158","author":"Le Berre C","year":"2020","unstructured":"Le Berre C, Sandborn WJ, Aridhi S, et al.. Application of artificial intelligence to gastroenterology and hepatology. Gastroenterology. 2020, 158:76-94.e2. 10.1053\/j.gastro.2019.08.058","journal-title":"Gastroenterology"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46486","article-title":"Advancements in heart failure management: a comprehensive narrative review of emerging therapies","volume":"15","author":"Sapna F","year":"2023","unstructured":"Sapna F, Raveena F, Chandio M, et al.. Advancements in heart failure management: a comprehensive narrative review of emerging therapies. Cureus. 2023, 15:e46486. 10.7759\/cureus.46486","journal-title":"Cureus"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46484","article-title":"Advancements in the management of endocrine system disorders and arrhythmias: a comprehensive narrative review","volume":"15","author":"Kumari Y","year":"2023","unstructured":"Kumari Y, Bai P, Waqar F, et al.. Advancements in the management of endocrine system disorders and arrhythmias: a comprehensive narrative review. Cureus. 2023, 15:e46484. 10.7759\/cureus.46484","journal-title":"Cureus"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46033","article-title":"Integrative medicine approaches: bridging the gap between conventional and renal complementary therapies","volume":"15","author":"Kalariya Y","year":"2023","unstructured":"Kalariya Y, Kumar A, Ullah A, et al.. Integrative medicine approaches: bridging the gap between conventional and renal complementary therapies. Cureus. 2023, 15:e46033. 10.7759\/cureus.46033","journal-title":"Cureus"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45958","article-title":"Holistic approaches to arrhythmia management: combining medication, ablation, and device interventions","volume":"15","author":"Chaudhary MH","year":"2023","unstructured":"Chaudhary MH, Dev S, Kumari A, et al.. Holistic approaches to arrhythmia management: combining medication, ablation, and device interventions. Cureus. 2023, 15:e45958. 10.7759\/cureus.45958","journal-title":"Cureus"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45835","article-title":"Cardiovascular complications of diabetes: from microvascular to macrovascular pathways","volume":"15","author":"Zakir M","year":"2023","unstructured":"Zakir M, Ahuja N, Surksha MA, et al.. Cardiovascular complications of diabetes: from microvascular to macrovascular pathways. Cureus. 2023, 15:e45835. 10.7759\/cureus.45835","journal-title":"Cureus"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45578","article-title":"Advancements in myocardial infarction management: exploring novel approaches and strategies","volume":"15","author":"Sachdeva P","year":"2023","unstructured":"Sachdeva P, Kaur K, Fatima S, et al.. Advancements in myocardial infarction management: exploring novel approaches and strategies. Cureus. 2023, 15:e45578. 10.7759\/cureus.45578","journal-title":"Cureus"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43882","article-title":"Exploring the complex connection between diabetes and cardiovascular disease: analyzing approaches to mitigate cardiovascular risk in patients with diabetes","volume":"15","author":"Jyotsna F","year":"2023","unstructured":"Jyotsna F, Ahmed A, Kumar K, et al.. Exploring the complex connection between diabetes and cardiovascular disease: analyzing approaches to mitigate cardiovascular risk in patients with diabetes. Cureus. 2023, 15:e43882. 10.7759\/cureus.43882","journal-title":"Cureus"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43279","article-title":"Deciphering the dilemma: anticoagulation for heart failure with preserved ejection fraction (HFpEF)","volume":"15","author":"Jyotsna F","year":"2023","unstructured":"Jyotsna F, Mahfooz K, Sohail H, et al.. Deciphering the dilemma: anticoagulation for heart failure with preserved ejection fraction (HFpEF). Cureus. 2023, 15:e43279. 10.7759\/cureus.43279","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/211919-diagnosis-and-treatment-of-liver-disease-current-trends-and-future-directions","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:49Z","timestamp":1707509509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/211919-diagnosis-and-treatment-of-liver-disease-current-trends-and-future-directions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,4]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.49920","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,4]]}}}